Trials / Completed
CompletedNCT04793529
Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Benha University · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Vitamin D3 plays important role in keratinocyte differentiation and had been used recently in verruca vulgaris. Aim of the work: To assess the expression of involucrin in verrucae vulgaris before and after injection of vitamin D3. Subjects and Methods: This study included 60 patients with verrucae vulgaris subjected to intralesional injection of vitamin D3 at three weeks interval for a maximum of five sessions. Immunohistochemical assessment of involucrin was done before and after injection and compared to skin biopsies from 30 healthy individuals
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cholecalciferol | Cholecalciferol injection |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2019-10-01
- Completion
- 2019-10-01
- First posted
- 2021-03-11
- Last updated
- 2023-07-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04793529. Inclusion in this directory is not an endorsement.